Dare Bioscience, Inc. DARE
NASDAQ · United States · Health Technology
$0.8500-0.00 (-0.12%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.20 | -0.30 | +32.6% | $187.55K | +11,150.5% | -35.4%$1.44→$0.93 |
| Q1 2026 | 2026-05-14 | -0.20 | -0.30 | +33.3% | — | — | -23.6%$2.84→$2.17 |
| Q4 2025 | 2026-03-26 | -0.10 | -0.42 | +76.2% | — | — | +10.7%$1.40→$1.55 |
| Q3 2025 | 2025-11-13 | -0.28 | -0.40 | +30.0% | — | — | -6.1%$1.98→$1.86 |
| Q2 2025 | 2025-08-14 | -0.45 | -0.58 | +22.4% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.50 | -0.58 | +13.8% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.65 | -0.63 | -3.2% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.55 | -0.71 | +22.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.